An inflammatory pathway of IFN-γ production in coronary atherosclerosis

Journal of Immunology

Volumn 178, Issue 1, 2007, Pages 592-604

  Ranjbaran, Hooman ^a   Sokol, Seth I ^a   Gallo, Amy ^a   Eid, Raymond E ^a   Iakimov, Alexander O ^a   D'Alessio, Alessio ^a   Kapoor, John R ^a   Akhtar, Shamsuddin ^a   Howes, Christopher J ^a   Aslan, Mihaela ^a   Pfau, Steven ^a   Pober, Jordan S ^a   Tellides, George ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; T LYMPHOCYTE RECEPTOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART CATHETERIZATION; HUMAN; HUMAN TISSUE; INFLAMMATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 33845946200     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.1.592     Document Type: Article

References (55)

1. Hansson, G. K., P. Libby, U. Schonbeck, and Z. Q. Yan. 2002. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91: 281-291.
2. Epstein, S. E., Y. F. Zhou, and J. Zhu. 1999. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100: e20-e28.
3. Lehr, H. A., T. A. Sagban, C. Ihling, U. Zahringer, K. D. Hungerer, M. Blumrich, K. Reifenberg, and S. Bhakdi. 2001. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 104: 914-920.
4. Finch, C. E., and E. M. Crimmins. 2004. Inflammatory exposure and historical changes in human life-spans. Science 305: 1736-1739.
5. Abbas, A. K., A. H. Lichtman, and J. S. Pober. 2000. Cytokines. In Cellular and Molecular Immunology, 2nd Ed. W.B. Saunders Company, Philadelphia, pp. 235-269.
6. Zhou, R. H., Q. Shi, H. Q. Gao, and B. J. Shen. 2001. Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population. J. Atheroscler. Thromb. 8: 30-32.
7. Yamashita, H., K. Shimada, E. Seki, H. Mokuno, and H. Daida. 2003. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am. J. Cardiol. 91: 133-136.
8. Fernandes, J. L., R. L. Mamoni, J. L. Orford, C. Garcia, A. P. Selwyn, O. R. Coelho, and M. H. Blotta. 2004. Increased Th1 activity in patients with coronary artery disease. Cytokine 26: 131-137.
9. Nijm, J., A. Wikby, A. Tompa, A. G. Olsson, and L. Jonasson. 2005. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am. J. Cardiol. 95: 452-456.
10. Kawai, T., and S. Akira. 2005. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17: 338-344.
11. Hirschfeld, M., J. J. Weis, V. Toshchakov, C. A. Salkowski, M. J. Cody, D. C. Ward, N. Qureshi, S. M. Michalek, and S. N. Vogel. 2001. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69: 1477-1482.
12. Uyemura, K., L. L. Demer, S. C. Castle, D. Jullien, J. A. Berliner, M. K. Gately, R. R. Warrier, N. Pham, A. M. Fogelman, and R. L. Modlin. 1996. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J. Clin. Invest. 97: 2130-2138.
13. Frostegard, J., A. K. Ulfgren, P. Nyberg, U. Hedin, J. Swedenborg, U. Andersson, and G. K. Hansson. 1999. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145: 33-43.
14. Liuzzo, G., S. L. Kopecky, R. L. Frye, W. M. O'Fallon, A. Maseri, J. J. Goronzy, and C. M. Weyand. 1999. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 100: 2135-2139.
15. Burns, W. R., Y. Wang, P. C. Tang, H. Ranjbaran, A. Iakimov, J. Kim, M. Cuffy, Y. Bai, J. S. Pober, and G. Tellides. 2005. Recruitment of CXCR3 and CCR5 T cells and production of interferon-γ-inducible chemokines in rejecting human arteries. Am. J. Transplant. 5: 1226-1236.
16. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153: 2533-2543.
17. De Servi, S., A. Mazzone, G. Ricevuti, I. Mazzucchelli, G. Fossati, D. Gritti, L. Angoli, and G. Specchia. 1995. Clinical and angiographic correlates of leukocyte activation in unstable angina. J. Am. Coll. Cardiol. 26: 1146-1150.
18. Mazzone, A., S. De Servi, M. Vezzoli, G. Fossati, I. Mazzucchelli, D. Gritti, E. Ottini, A. Mussini, and G. Specchia. 1999. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 145: 369-374.
19. Takeshita, S., H. Hashimoto, Y. Ono, M. Ochiai, N. Yokoyama, M. Terakura, T. Sato, and T. Isshiki. 2001. Increased leukocyte activity as a predictor for flow-limiting coronary lesions in patients with angina pectoris. Atherosclerosis 158: 477-481.
20. Gupta, S., A. M. Pablo, X. Jiang, N. Wang, A. R. Tall, and C. Schindler. 1997. IFN-γ potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99: 2752-2761.
21. Lee, T. S., H. C. Yen, C. C. Pan, and L. Y. Chau. 1999. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19: 734-742.
22. -/- mice through release of interferon-γ. Circ. Res. 90: E34-E38.
23. -/- mice. J. Interferon Cytokine Res. 22: 661-670.
24. Elhage, R., J. Jawien, M. Rudling, H. G. Ljunggren, K. Takeda, S. Akira, F. Bayard, and G. K. Hansson. 2003. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc. Res. 59: 234-240.
25. Davenport, P., and P. G. Tipping. 2003. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 163: 1117-1125.
26. Veillard, N. R., S. Steffens, G. Pelli, B. Lu, B. R. Kwak, C. Gerard, I. F. Charo, and F. Mach. 2005. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation 112: 870-878.
27. Sabatine, M. S., and E. Braunwald. 2005. Another look at the age-old question: which came first, the elevated C-reactive protein or the atherothrombosis? J. Am. Coll. Cardiol. 45: 244-245.
28. Blankenberg, S., L. Tiret, C. Bickel, D. Peetz, F. Cambien, J. Meyer, and H. J. Rupprecht, for the AtheroGene Investigators. 2002. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106: 24-30.
29. Millonig, G., G. T. Malcom, and G. Wick. 2002. Early inflammatory- immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 160: 441-448.
30. Gerdes, N., G. K. Sukhova, P. Libby, R. S. Reynolds, J. L. Young, and U. Schonbeck. 2002. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J. Exp. Med. 195: 245-257.
31. Tenger, C., A. Sundborger, J. Jawien, and X. Zhou. 2005. IL-18 accelerates atherosclerosis accompanied by elevation of IFN-γ and CXCL16 expression independently of T cells. Arterioscler. Thromb. Vasc. Biol. 25: 791-796.
32. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
33. Berenson, L. S., N. Ota, and K. M. Murphy. 2004. Issues in T-helper 1 development: resolved and unresolved. Immunol. Rev. 202: 157-174.
34. Yang, J., H. Zhu, T. L. Murphy, W. Ouyang, and K. M. Murphy. 2001. IL-18-stimulated GADD45 β required in cytokine-induced, but not TCR-induced, IFN-γ production. Nat. Immunol. 2: 157-164.
35. Beadling, C., and M. K. Slifka. 2005. Differential regulation of virus-specific T-cell effector functions following activation by peptide or innate cytokines. Blood 105: 1179-1186.
36. Wick, G., M. Romen, A. Amberger, B. Metzler, M. Mayr, G. Falkensammer, and Q. Xu. 1997. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J. 11: 1199-1207.
37. Tellides, G., D. A. Tereb, N. C. Kirkiles-Smith, R. W. Kim, J. H. Wilson, J. S. Schechner, M. I. Lorber, and J. S. Pober. 2000. Interferon-γ elicits arteriosclerosis in the absence of leukocytes. Nature 403: 207-211.
38. Ramshaw, A. L., and D. V. Parums. 1992. Combined immunohistochemical and immunofluorescence method to determine the phenotype of proliferating cell populations. J. Clin. Pathol. 45: 1015-1017.
39. O'Brien, E. R., C. E. Alpers, D. K. Stewart, M. Ferguson, N. Tran, D. Gordon, E. P. Benditt, T. Hinohara, J. B. Simpson, and S. M. Schwartz. 1993. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ. Res. 73: 223-231.
40. Stemme, S., L. Rymo, and G. K. Hansson. 1991. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab. Invest. 65: 654-660.
41. Swanson, S. J., A. Rosenzweig, J. G. Seidman, and P. Libby. 1994. Diversity of T-cell antigen receptor Vβ gene utilization in advanced human atheroma. Arterioscler. Thromb. 14: 1210-1214.
42. Oksenberg, J. R., G. T. Stavri, M. C. Jeong, N. Garovoy, J. R. Salisbury, and J. D. Erusalimsky. 1997. Analysis of the T-cell receptor repertoire in human atherosclerosis. Cardiovasc. Res. 36: 256-267.
43. Dong, C., J. E. Wilson, G. L. Winters, and B. M. McManus. 1996. Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab. Invest. 74: 921-931.
44. de Boer, O. J., A. C. van der Wal, C. E. Verhagen, and A. E. Becker. 1999. Cytokine secretion profiles of cloned T cells from human aortic atherosclerotic plaques. J. Pathol. 188: 174-179.
45. Boyle, J. J., D. E. Bowyer, P. L. Weissberg, and M. R. Bennett. 2001. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arterioscler. Thromb. Vasc. Biol. 21: 1402-1407.
46. Liuzzo, G., J. J. Goronzy, H. Yang, S. L. Kopecky, D. R. Holmes, R. L. Frye, and C. M. Weyand. 2000. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101: 2883-2888.
47. Caligiuri, G., G. Paulsson, A. Nicoletti, A. Maseri, and G. K. Hansson. 2000. Evidence for antigen-driven T-cell response in unstable angina. Circulation 102: 1114-1119.
48. De Palma, R., F. Del Galdo, G. Abbate, M. Chiariello, R. Calabro, L. Forte, G. Cimmino, M. F. Papa, M. G. Russo, G. Ambrosio, et al. 2006. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation 113: 640-646.
49. Nakajima, T., S. Schulte, K. J. Warrington, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand. 2002. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105: 570-575.
50. Nakajima, T., O. Goek, X. Zhang, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand. 2003. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ. Res. 93: 106-113.
51. Pryshchep, S., K. Sato, J. J. Goronzy, and C. M. Weyand. 2006. T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ. Res. 98: 1168-1176.
52. Fei, G. Z., Y. H. Huang, J. Swedenborg, and J. Frostegard. 2003. Oxidised LDL modulates immune-activation by an IL-12 dependent mechanism. Atherosclerosis 169: 77-85.
53. Zhang, X., A. Niessner, T. Nakajima, W. Ma-Krupa, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand. 2006. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ. Res. 98: 524-531.
54. Ait-Oufella, H., B. L. Salomon, S. Potteaux, A. K. Robertson, P. Gourdy, J. Zoll, R. Merval, B. Esposito, J. L. Cohen, S. Fisson, et al. 2006. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12: 178-180.
55. Kusaba, H., P. Ghosh, R. Derin, M. Buchholz, C. Sasaki, K. Madara, and D. L. Longo. 2005. Interleukin-12-induced interferon-γ production by human peripheral blood T cells is regulated by mammalian target of rapamycin (mTOR). J. Biol. Chem. 280: 1037-1043.